FindTrial
Sign In

Maintenance therapy with bacillus Calmette-Guérin Connaught stain for non-muscle invasive bladder cancer after transurethral resection: prospective study with low-dose instillation.

Maintenance therapy with bacillus Calmette-Guérin Connaught stain for non-muscle invasive bladder cancer after transurethral resection: prospective study with low-dose instillation. - Maintenance therapy with bacillus Calmette-Guérin Connaught stain for non-muscle invasive bladder cancer after transurethral resection: prospective study with low-dose instillation.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000006362
Enrollment
30
Registered
2011-09-16
Start date
2011-06-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non muscle-invasive bladder cancer

Interventions

None listed

Sponsors

Graguate school of Medicine, Yamaguchi University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1 Diagnosed NMIBC by histopathological study. 2 Number of tumors is more than three, more than three times recurrences or recurrence within 1 year 3 Patients who accept this study

Exclusion criteria

Exclusion criteria: 1 Patients who have current or previous upper tract tumor. 2 Patients whose bladder volume is less than 100 ml, which is mesured by uktrasonography. 3 Patients who suffered with urinary frequency (OAB symptom score<=6) 4 Patients who received BCG theraphy previously. 5 Patients who have contraindication of BCG.

Design outcomes

Primary

MeasureTime frame
1. Incidence rate of adverse events 2. Rate of Patients who accomplish the protocol of this study—

Secondary

MeasureTime frame
Recurrence- and progression-rate during 2-year after the final instillation—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026